We could not find any results for:
Make sure your spelling is correct or try broadening your search.
hVIVO PLC 05 October 2023 hVIVO plc ("hVIVO" or the "Company") Positive results from influenza human challenge study conducted by hVIVO Pneumagen to advance antiviral...
hVIVO PLC 26 April 2023 hVIVO plc ("hVIVO" or the "Company") FDA grants Breakthrough Therapy and Fast Track designations to SAB Biotherapeutics' influenza candidate Data...
hVIVO PLC 03 April 2023 hVIVO plc ("hVIVO" or the "Company") Positive results from influenza human challenge study conducted by hVIVO hVIVO plc (AIM & Euronext: HVO...
hVIVO PLC 29 March 2023 hVIVO plc ("hVIVO" or the "Company") World Vaccine Congress Presentation hVIVO plc (AIM & Euronext: HVO) , (formerly Open Orphan plc) a rapidly...
hVIVO PLC 17 January 2023 hVIVO plc ("hVIVO" or the "Company") EUR3.2m contract for Venn Life Sciences with global pharmaceutical client For provision of pharmacokinetic and...
hVIVO PLC 19 December 2022 hVIVO plc ("hVIVO" or the "Company") Phase I results for Imutex's mosquito vaccine candidate published in leading peer-reviewed journal hVIVO...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions